Patient Opportunity A (LGOAX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

53.48

+0.21 (0.39%)

At close: Nov 3, 2026

Fund Assets	2.07B
Expense Ratio	1.647%
Min. Investment	$1,000
Turnover	27.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	n/a

Previous Close	53.27
YTD Return	10.18%
1-Year Return	13.93%
5-Year Return	40.95%
52-Week Low	43.48
52-Week High	57.76
Beta (5Y)	1.95
Holdings	40
Inception Date	Feb 3, 2009

About LGOAX

Patient Opportunity Trust - Class A is a mutual fund focused on achieving long-term capital growth through a distinctive, value-oriented investment approach. Managed by an experienced team, the fund seeks out companies that are believed to be cyclically or secularly mispriced, spanning various investment styles, security types, industries, sectors, and market capitalizations. Operating with a high active share, the fund maintains a concentrated portfolio that is notably differentiated from broad market indices such as the S&P 500, offering diversification to investors with core equity holdings. The management team employs a contrarian and opportunistic strategy, aiming to maximize returns over multi-year periods through a flexible investment process. Patient Opportunity Trust – Class A has a history of navigating market cycles and maintains a relatively moderate portfolio turnover, reflecting its long-term perspective. The fund holds a mix of well-known companies as top holdings, with a focus on mid-cap stocks and a value tilt, positioning it as a complement to traditional equity portfolios in the mutual fund landscape.

Fund Family Patient Capital Management

Category Mid-Cap Value

Performance Rating Below Average

Risk Rating High

Stock Exchange Nasdaq

Ticker Symbol LGOAX

Share Class Class A

Index S&P 500 TR

Performance

LGOAX had a total return of 13.93% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.39%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
SWANX	Schwab	Schwab Core Equity Fund™	0.72%
FAMRX	Fidelity	Fidelity Asset Manager 85%	0.62%
FBRNX	Fidelity	Fidelity Advisor Stock Sel I	0.53%
FDSSX	Fidelity	Fidelity Stock Selector Fund	0.49%
FEYAX	Fidelity	Fidelity Advisor Asset Manager 85% A	0.92%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MVISX	Class Is	1.33%
LMNOX	Class I	1.39%
LMOFX	Class Fi	1.74%
LMORX	Class R	1.94%

Top 10 Holdings

50.02% of assets

Name	Symbol	Weight
Royalty Pharma plc	RPRX	6.13%
Citigroup Inc.	C	5.67%
Alphabet Inc.	GOOGL	5.65%
Precigen Warrant Restricted	n/a	5.59%
Amazon.com, Inc.	AMZN	5.18%
NVIDIA Corporation	NVDA	5.00%
UnitedHealth Group Incorporated	UNH	4.82%
Precigen, Inc.	PGEN	4.50%
Meta Platforms, Inc.	META	3.81%
QXO, Inc.	QXO	3.68%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 27, 2024	$0.02059	Dec 27, 2024

Full Dividend History